169323 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids; Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors Interleukin
CD11B AGONISTS FOR TREATMENT OF AUTOIMMUNE DISEASE
#2COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34
#3COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34
#4USE OF MONOLITHIC ANION EXCHANGE CHROMATOGRAPHY AND LIGHT SCATTERING FOR QUANTIFYING EXTRACELLULAR VESICLES
#5SYSTEM AND METHOD OF IDENTIFICATION OF A SPECIFIC ALKYLAMIDE FOR THE TREATMENT OF RESPIRATORY VIRUS INFECTIONS
#6METHODS AND SYSTEMS FOR RAPID DETECTION OF STROKE AND DETERMINATION OF ONSET VIA NEUROINFLAMMATION BIOMARKERS
#7METAL NANOPARTICLE, AND PLASMONIC BIOSENSOR COMPRISING THE SAME
#8NON-SPECIFIC REACTION INHIBITOR, METHOD FOR USING NON-SPECIFIC REACTION INHIBITOR, METHOD FOR INHIBITING NON-SPECIFIC REACTION, BIOCHEMICAL MEASUREMENT REAGENT, SPECIMEN PRETREATMENT SOLUTION, AND BIOCHEMICAL MEASUREMENT REAGENT KIT
#9METHOD OF ASSESSING ANTI-PRURITIC ACTIVITY OF A CANINE ANTI-IL-31 ANTIBODY CANDIDATE
#10METHOD OF SELECTING PATIENTS FOR TREATMENT WITH AN IL-33 AXIS ANTAGONIST
#11Ultrasensitive Protein Detection using a Proximity Immunoassay with Nucleic Acid Target Amplification and Photonic Resonator Absorption Microscopy (PINATA)
#12METHOD FOR SCREENING AND PREPARING IMMUNOMODULATOR
#13ANAKINRA FOR THE TREATMENT OF POST ACUTE COVID SYNDROME
#14METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#15METHODS FOR DETECTING METEORIN-BETA ACTIVITY
#16METHODS FOR DETECTING METEORIN-BETA ACTIVITY
#17NOVEL INTERLEUKIN-17A (IL-17A)-DERIVED PEPTIDE AND NEUTRALIZING ANTIBODY (AB17-IPL-1)
#18METHODS OF TREATING MALIGNANT GLIOMAS
#19BIOMARKERS FOR ALLERGEN IMMUNOTHERAPY
#20SINGLE CELL SECRETOME ANALYSIS
#21METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#22SYSTEM FOR DETECTING INFECTION IN SYNOVIAL FLUID
#23Methods, Kits and Compositions for Assessing and Treating Interstitial Cystitis
#24PEPTIDE VACCINES AGAINST INTERLEUKIN-31
#25METHODS RELATING TO IMPAIRED RESPIRATORY HEALTH THERAPEUTICS
#26DECOY CYTOKINE RECEPTOR
#27NOVEL CYTOKINE-BASED THERAPIES AND METHODS
#28CHEMICAL SCREEN OF MODULATORS FOR VACCINE ADJUVANTS
#29METHODS OF TREATING IMMUNOTHERAPY-ASSOCIATED ADVERSE EFFECTS
#30COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34
#31METHOD FOR PREDICTING ATOPIC DERMATITIS RELAPSE
#32Method of Peptide Library Construction and Peptides Thereof
#33BIOMARKER-BASED TREATMENT AND DIAGNOSTIC METHODS FOR IL-17-DEPENDENT CONDITIONS
#34EX VIVO COLONIC BIOPSY PLATFORM TO EVALUATE MULTI-OMIC SIGNATURES FOR SCREENING CANDIDATE THERAPEUTICS
#35NITRILOTRIACETIC ACID LINKERS, SOLID PHASE SYNTHESIS OF NITRILOTRIACETIC ACID LINKERS AND APPLICATIONS THEREOF
#36METHOD OF CHARACTERIZING TUMORS
#37CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT
#38COMPANION DIAGNOSTICS AND STRATEGIES FOR TREATMENT WITH AN ARYL HYDROCARBON RECEPTOR AGONIST COMPOUND
#39ANTI-IL-4RA ANTIBODIES AND USES THEREOF
#40IL-18 BINDING PROTEIN (IL-18BP) IN THE TREATMENT OF VEXAS
#41Biosignatures for Fatigue Syndromes
#42USE OF GAMMA PRIME FIBRINOGEN AS A BIOMARKER IN THE ASSESSMENT OF COVID-19 INFECTIONS AND PROGNOSIS OF SEVERE DISEASE
#43METHODS AND RELATED ASPECTS FOR PERFORMING LABEL-FREE SINGLE-MOLECULE IMMUNOASSAYS
#44Treating Chronic Myelomonocytic Leukemia with CXCL8 Receptor Inhibitors
#45NLRP3 Variants & Library Screen for NLRP3 Inhibitors with the Same
#46ANTI-IL-27 ANTIBODIES AND USES THEREOF
#47Methods of Predicting Food Allergy
#48Serum Immune-Based Biomarkers for Use in ALS Therapy
#49ANTI-IL13RA2 ANTIBODIES AND USES THEREOF
#50METHOD OF IMPROVING THE CONSISTENCY AND/OR QUALITY OF A FELINE ANTIBODY
#51METHOD AND APPARATUS FOR PREPARING PLASMA ENRICHED IN IL-1RA
#52BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSTIC TEST
#53PRODUCTS AND USES THEREOF FOR PREDICTING THE SENSITIVITY OF A SUBJECT TO CANCER IMMUNOTHERAPY INVOLVING AN ANTI-PD(L)1 AND AN ANTI-ANGIOGENIC AGENT, AND FOR SELECTING OPTIMIZED THERAPY
#54METHODS OF TREATING MALIGNANT GLIOMAS
#55COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION
#56NOVEL ANTI-TSLP ANTIBODIES
#57DIAGNOSTICS OF MILD OR ADVANCED PERIODONTITIS BASED ON SALIVARY IL-1BETA AND MMP-9
#58BIOMARKER SIGNATURES INDICATIVE OF EARLY STAGES OF CANCER
#59NOVEL ANTI-IL-36R ANTIBODIES
#60ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF
#61PROTEIN SIGNATURES FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS
#62ANTI IL-36R ANTIBODIES
#63Binding Molecules Targeting IL-2 Receptor
#64Stabilized IL-18 Polypeptides and Uses Thereof
#65MINIMALLY-INVASIVE MEASUREMENT OF ESOPHAGEAL INFLAMMATION
#66METHODS FOR QUANTIFYING IL-33
#67METHODS FOR DETERMINING RESPONSIVENESS TO TYK2 INHIBITORS
#68METHODS AND SYSTEMS FOR DETECTING URINARY TRACT INFECTIONS
#69EARLY DIAGNOSIS OF INFECTIONS
#70COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNITY, INCLUDING AUTOIMMUNITY ASSOCIATED WITH CANCER AND CANCER THERAPY
#71BIOMARKERS TO DETECT RISK OF SINUSOIDAL OBSTRUCTION SYNDROME
#72TREATMENT OF AGING FRAILTY COMPRISING ADMINISTERING BONE MARROW DERIVED MESENCHYMAL STEM CELLS
#73VAGUS NERVE STIMULATION PRE-SCREENING TEST
#74IL-17F AND IL-17A-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#75STEROID SPARING
#76SCREENING DONOR LUNGS FOR LUNG TRANSPLANTATION
#77Methods, Assays and Systems for Detection of a Target Analyte
#78ANTI-NR10 ANTIBODY AND USE THEREOF
#79BIOMARKERS PREDICTIVE OF CYTOKINE RELEASE SYNDROME
#80IL4/IL13 RECEPTOR MOLECULE FOR VETERINARY USE
#81IL4/IL13 RECEPTOR MOLECULES FOR VETERINARY USE
#82FUNCTIONAL CELL-BASED POTENCY ASSAY FOR MEASURING BIOLOGICAL ACTIVITY OF INTERLEUKIN 2 (IL-2) ANALOGS
#83IL6 MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#84ANALYSIS OF EFFLUENT
#85IL-17A BINDING PROTEINS
#86IL-18 Binding Protein (IL-18BP) and Antibodies for Treating Inflammatory Diseases
#87PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#88ANTIBODY AND USE THEREOF FOR THE TREATMENT OF CANCER
#89HEMATOPOIETIC CELL PHENOTYPING USING CIRCULATING CELL-FREE MARKERS
#90Precision Medicine Approach to Targeting Neurodegeneration
#91TRICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, AUTOIMMUNE AND INFLAMMATORY DISORDERS
#92COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34
#93THERAPEUTIC AND DIAGNOSTIC METHODS FOR IL-33-MEDIATED DISORDERS
#94INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING
#95ANTAGONIST OF INTERLEUKIN-17B RECEPTOR (IL-17RB) AND USE THEREOF
#96TNF-ALPHA AND IL-1ALPHA POSITIVE COPD TREATMENT WITH ANTIBIOTICS
#97METHODS AND COMPOSITIONS RELATED TO TOXICITY ASSOCIATED WITH CELL THERAPY
#98BIOMARKER COMBINATIONS TO SIMULTANEOUSLY EVALUATE NON-ALCOHOLIC STEATOHEPATITIS AND HEPATIC FIBROSIS STATUS
#99COMPOSITION COMPRISING INHIBITOR AGAINST EXPRESSION OF EXOSOMAL PD-L1 AS ACTIVE INGREDIENT FOR ENHANCING ANTICANCER EFFECT
#100DIAGNOSTIC METHODS FOR T CELL THERAPY
#101CLOSTRODIOIDES DIFFICILE TREATMENT
#102HUMAN ANTIBODY SPECIFIC FOR INTERLEUKIN-1ALPHA
#103METHODS FOR MODULATING HOST CELL SURFACE INTERACTIONS WITH SARS-COV-2
#104USES OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPIES IN COMBINATION WITH INHIBITORS OF INFLAMMATION-RELATED SOLUBLE FACTORS
#105BIOMARKER-BASED RISK MODEL TO PREDICT PERSISTENT MULTIPLE ORGAN DYSFUNCTION AFTER CONGENITAL HEART SURGERY
#106ANTIBODY BINDING HUMAN IL-5R alpha AND USE THEREOF
#107ANTIBODY TARGETING INTERLEUKIN 36R, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#108ANTI-IL5 NANOANTIBODY AND USE THEREOF
#109METHOD FOR DETERMINING MORTALITY RISK OF INFECTIOUS INFLAMMATORY DISEASE ON BASIS OF CONCENTRATION OF WARS AND CYTOKINE
#110METHODS OF CLASSIFYING THE DIFFERENTIATION STATE OF CELLS AND RELATED COMPOSITIONS OF DIFFERENTIATED CELLS
#111APTAMERS THAT TARGET CXCL9
#112GENETIC ALTERATIONS ASSOCIATED WITH EOSINOPHILIC ESOPHAGITIS AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF DISEASE
#113Methods of Determining Immune Response
#114IMMUNOSTIMULATING IL-2 ANALOGS
#115METHODS FOR TREATING MULTIPLE MYELOMA AND THE USE OF COMPANION BIOMARKERS FOR 4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL)BENZYL)PIPERAZIN-1-YL)-3-FLUOROBENZONITRILE
#116METHODS OF DETERMINING RISK OF SUICIDE BY IMMUNOLOGICAL ASSESSMENT
#117HUMAN INNATE LYMPHOID CELL PRECURSORS: IDENTIFICATION, CHARACTERIZATION, APPLICATIONS
#118LONG-ACTING ANTI-IL31 ANTIBODIES FOR VETERINARY USE
#119Methods of Identifying Schizophrenia Patients At Risk for Relapse
#120SYSTEMS AND METHODS FOR DETECTING CYTOKINES
#121MULTIANALYTE ASSAY FOR THE SIMULTANEOUS DETECTION OF NUCLEIC ACID AND ANALYTES
#122DRUG-SPECIFIC PHARMACOKINETIC ASSAY FOR IL-15 SUPERAGONIST
#123TARGET TISSUE-SPECIFIC ANTIGEN-BINDING MOLECULE
#124COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34
#125COMBINATION THERAPY WITH ANTI-IL-8 ANTIBODIES AND ANTI-PD-1 ANTIBODIES FOR TREATING CANCER
#126KIT FOR QUANTITATIVE DETECTION USING FLUORESCENT MICROARRAY
#127Treatment Of Lung Disease Based Upon Stratification Of Polygenic Risk Score For Interleukin 33 (IL-33)
#128ANTI-INTERLEUKIN 36 RECEPTOR (IL-36R) THERAPY FOR ICHTHYOSIS
#129SEROLOGIC ASSAY FOR SILENT BRAIN ISCHEMIA
#130HIGH DOSE NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) PRECURSOR REGIMENS FOR REDUCTION OF INFLAMMATION IN HUMAN PATIENTS WITH PREEXISTING INFLAMMATION
#131ANTIBODY OF IL-11 AND USE THEREOF
#132NPERSEVERE: BIOMARKERS ESTIMATING BASELINE MORTALITY RISK FOR NEONATAL SEPSIS AND NECROTIZING ENTEROCOLITIS
#133IL-18 Binding Protein (IL-18BP) In Inflammatory Diseases
#134Identification of contact lens wearers predisposed to contact lens discomfort
#135MONOCLONAL ANTIBODIES TARGETED TO HUMAN TAXILIN ALPHA AND METHODS FOR USE OF SAME
#136METHOD AND KIT FOR THE EARLY DETECTION OF SEPSIS
#137Single Molecule Assays for Ultrasensitive Detection of Biomolecules
#138IL-5 BINDING MOLECULE, PREPARATION METHOD THEREFOR, AND USE THEREOF
#139SERUM BIOMARKERS FOR PREDICTING AND PREVENTING HEMORRHAGIC STROKE
#140TYPE 2 CYTOKINES AS PREDICTORS OF DISEASE SEVERITY AND/OR AS THERAPEUTIC TARGETS FOR COVID-19
#141POTENCY ASSAY
#142BIOMARKERS FOR VITILIGO
#143ASSESSMENT METHODS AND DIAGNOSTIC KIT FOR PREDICTING SUICIDAL BEHAVIORS IN PATIENTS WITH DEPRESSIVE DISORDERS USING MULTIMODAL SERUM BIOMARKERS
#144ASSESSMENT METHODS AND DIAGNOSTIC KIT FOR PREDICTING ACUTE ANTIDEPRESSANT RESPONSE AND REMISSION IN PATIENTS WITH DEPRESSIVE DISORDERS USING MULTIMODAL SERUM BIOMARKERS
#145Antibodies Against IL-1 Beta
#146METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION
#147TOCILIZUMAB FOR THE TREATMENT OF VIRAL INFECTIONS
#148ANTI-NR10 ANTIBODY AND USE THEREOF
#149ANTIBODY AND USES THEREOF
#150MIMINALLY-INVASIVE ATOPIC DERMATITIS TEST METHOD USING MICRONEEDLE PATCH AND MINIMALLY-INVASIVE ATOPIC DERMATITIS TEST KIT COMPRISING MICRONEEDLE PATCH
#151Compositions and Methods for the Systemic Treatment of Arthritis
#152BIOMARKERS FOR PREDICTING RESPONSE TO IL-6 ANTAGONIST IN COVID-19 PNEUMONIA
#153Immunostimulating IL-2 analogs
#154Use of Brazikumab to Treat Crohn's Disease
#155IL-1 Binding Proteins
#156METHODS AND SYSTEMS RELATED TO HIGHLY SENSITIVE ASSAYS AND DELIVERING CAPTURE OBJECTS
#157LABEL-FREE FOOD ANALYSIS AND MOLECULAR DETECTION
#158MITIGATION AND REVERSAL OF INTESTINAL FIBROSIS AND INFLAMMATION BY INHIBITION OF TL1A FUNCTION
#159METHODS OF TREATING OR PREVENTING SERIOUS SYMPTOMS FROM COVID-19 INFECTION
#160METHODS OF TREATING OR PREVENTING SERIOUS SYMPTOMS FROM COVID-19 INFECTION
#161METHODS FOR PREDICTION OF ANTI-TNF ALPHA DRUG LEVELS AND AUTOANTIBODY FORMATION
#162Compositions and methods for treating age-related diabetes and related disorders
#163TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION
#164SYSTEM FOR DETECTING INFECTION IN SYNOVIAL FLUID
#165ANTI-IL-27 ANTIBODIES AND USES THEREOF
#166HUMAN MONOCLONAL ANTIBODIES AGAINST INTERLEUKIN 8 (IL-8)
#167ASCAROSIDE TREATMENT OF EOSINOPHILIC ESOPHAGITIS
#168MYCOBACTERIAL COMPOSITIONS AND BIOMARKERS FOR USE IN TREATMENT AND MONITORING OF THERAPEUTIC RESPONSIVENESS
#169CAR-T-CELL THERAPY
#170METHOD FOR DIAGNOSING AND TREATING FIBROMYALGIA
#171COMPOSITIONS AND METHODS FOR AN IL-17 TARGET ENGAGEMENT ASSAY WITH LARGE MOLECULE MODULATORS
#172BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS
#173METHOD OF DETERMINING THE IDENTITY AND/OR AMOUNT OF AN ANTI-IL-31 ANTIBODY IN A SAMPLE
#174COMPOSITIONS AND METHODS FOR AN IL-17 TARGET ENGAGEMENT ASSAY WITH SMALL MOLECULE MODULATORS
#175METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASE SECONDARY TO MULTIPLE SCLEROSIS
#176IL-4R AS A BIOMARKER IN CANCER
#177DEVICE AND METHOD FOR DETECTING INFLAMMATION
#178Methods of prognosis and treatment
#179APPARATUS AND METHODS FOR FABRICATION OF NANOPATTERNED ARRAYS
#180COMPOSITION FOR CANCER DIAGNOSIS
#181Decoy cytokine receptor
#182NOVEL IL-17B ANTIBODIES
#183Therapeutically Triggering an Innate Immune Response in a Target Tissue
#184Early diagnosis of infections
#185METHOD FOR THE DETECTION OF CANCER
#186ANTIBODY TO HUMAN IL-1 BETA
#187METHOD OF DETERMINING THE PROBABILITY OF INFLAMMATORY BOWEL DISEASE IN A SUBJECT BEING ULCERATIVE COLITIS OR CROHN'S DISEASE
#188IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#189IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#190MARKER FOR STATIN TREATMENT STRATIFICATION IN HEART FAILURE
#191IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#192METHOD FOR CLASSIFYING AN ALLERGIC PATIENT AS ELIGIBLE TO ALLERGEN IMMUNOTHERAPY
#193IMMUNOTHERAPY FOR OPIOID ADDICTION
#194METHODS OF DETECTING SEPTIC ARTHRITIS, TRANSIENT SYNOVITIS AND OSTEOMYELITIS
#195SINGLE CELL SECRETOME ANALYSIS
#196LATERAL FLOW DEVICE
#197INTERLEUKIN-4-INDUCED GENE 1 (IL4I1) AS A BIOMARKER AND USES THEREOF
#198METHOD FOR TREATING ATOPIC DERMATITIS USING MONOCLONAL STEM CELLS
#199COMPOSITIONS AND METHODS FOR ENHANCING MUCOSAL IMMUNITY
#200NEW BIOMARKERS AND BIOTARGETS IN RENAL CELL CARCINOMA
#201CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT
#202Interleukin-31 monoclonal antibodies for veterinary use
#203Companion diagnostics for NSAIDS and donepezil for treating specific subpopulations of patients suffering from Alzheimer's disease
#204METHOD OF DIAGNOSIS
#205COMPOSITIONS AND METHODS RELATING TO C5L2
#206USE OF PERIPHERAL BLOOD PRO- AND ANTI-INFLAMMATORY CYTOKINE RATIOS AS MARKERS OF IMPLANTATION PRECEDING PREGNANCY
#207Compositions and Methods to Detect Non-Coeliac Gluten Sensitivity
#208NOVEL CYTOKINES AND USE THEREOF
#209METHOD FOR DETECTING IMMINENT CHILDBIRTH
#210IL-6 SIGNALING AND BREAST CANCER
#211Anti-IL-23 antibodies, compositions, methods and uses
#212BIOMARKERS
#213Anti-IL4 Receptor Antibodies for Veterinary Use
#214USES OF IL-40 AND METHODS FOR DETECTING IL-40 ACTIVITY
#215Vagus nerve stimulation pre-screening test
#216Methods of treating chronic disorders with complement inhibitors
#217METHODS FOR DETECTING METEORIN-BETA ACTIVITY
#218ASCAROSIDE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
#219Protein signatures for distinguishing between bacterial and viral infections
#220TH17 DIFFERENTIATION MARKERS FOR ACNE AND USES THEREOF
#221CXCL8 Binding Nucleic Acids
#222Human antibody having high affinity to human IL-4 receptor alpha
#223ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1
#224DETECTION AND TREATMENT OF IL-17 AND IL-13 RELATED CONDITIONS
#225IL4/IL13 Receptor Molecule for Veterinary Use
#226Multi-level specific targeting of cancer cells
#227Compositions and Methods for Discriminating Infectious from Non-Infectious CNS Disorders
#228Method for diagnosis and subtyping of adult onset Still's disease
#229Antibodies to IL-34
#230COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#231Ratio of immune cells as prognostic indicator of therapeutic success in allergen-specific immunotherapy
#232Methods of treating or preventing serious symptoms from COVID-19 infection
#233CONTROLLED RELEASE OF ANTIBODIES TO MODULATE CYTOKINES
#234PREDICTING MORTALITY AND DETECTING SEVERE DISEASE
#235NOVEL THERAPY
#236NOVEL BIOMARKERS FOR RECURRENT TONSILLITIS
#237ANTI-IL-6 RECEPTOR ANTIBODY
#238METHODS OF QUANTIFYING LIF AND USES THEREOF
#239IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases
#240Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile
#241HUMAN ANTIBODY SPECIFIC FOR INTERLEUKIN-1ALPHA
#242Methods of Treating Cardiovascular Diseases and Predicting the Efficacy of Exercise Therapy
#243Methods for guiding therapy decisions in seizure disorders
#244Pencil-like optical fiber sensor probe, portable immunosensor and use thereof
#245Treatment of Placental Chronic Histiocytic Intervillositis Using an Inhibitor of Interleukin-1
#246METHOD FOR MEASURING SYSTEMIC CHRONIC INFLAMMAGING
#247Human innate lymphoid cell precursors: identification, characterization, applications
#248HUMAN MONOCLONAL ANTIBODIES AGAINST CD25
#249Use of Brazikumab to Treat Crohn's Disease
#250DENDRITIC CELL POTENCY ASSAY
#251Method and platform for detecting immunogenicity of tumor neoantigen
#252Combination therapy with anti-IL-8 antibodies and anti-PD-1 antibodies for treating cancer
#253METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF SEPSIS
#254Materials and methods for implementing immunoassay on microneedle patch for detection and quantification of bioanalytes in interstitial fluid
#255Methods for quantifying IL-33
#256METHOD FOR DETERMINING VACCINE EFFICACY IN AN INDIVIDUAL AND MEANS THEREFORE
#257IL-17F-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#258DIAGNOSIS FOR VARIOUS DISEASES USING TUMOR MICROENVIRONMENT ACTIVE PROTEINS
#259Methods and Compositions for Modulating TH-GM Cell Function
#260In vitro immune synapse system and method of in vitro evaluating immune response using the same
#261Biocompatible and bioabsorbable derivatized chitosan compositions
#262IL-18 binding protein (IL-18BP) in inflammatory diseases
#263IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#264IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases
#265IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#266Specific-binding polypeptides and uses thereof
#267BIOMARKERS USEFUL IN THE TREATMENT OF IL-23A RELATED DISEASES
#268Nucleic acids encoding antibodies against IL-1 beta
#269Minimally-invasive measurement of esophageal inflammation
#270Biomarkers for vitiligo
#271IL-17A binding proteins
#272Compositions and methods for the systemic treatment of arthritis
#273SOLUBLE HUMAN ST-2 ANTIBODIES AND ASSAYS
#274Methods of treating chronic disorders with complement inhibitors
#275Phosphate and tensin homolog (PTEN) for the detection of autoimmune diseases or conditions
#276CALIXCROWNS AND USES THEREOF
#277Biomarkers related to organ function
#278N-TERMINALLY TRUNCATED INTERLEUKIN-38
#279Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
#280DIAGNOSTIC MARKERS FOR BOVINE TUBERCULOSIS AND USES THEREOF
#281INTERLEUKIN 32 AS A BIOMARKER OF TYPE 1 DIABETES
#282METHODS AND KITS FOR DIAGNOSIS OF FAMILIAL MEDITERRANEAN FEVER
#283KIT FOR IN VITRO OR EX VIVO MEASUREMENT OF THE EXPRESSION OF sCD127 IN A BIOLOGICAL SAMPLE
#284Biomarker combinations to simultaneously evaluate non-alcoholic steatohepatitis and hepatic fibrosis status
#285BIOMARKERS IN EX VIVO LUNG PERFUSION (EVLP) PERFUSATE
#286Antibody to human IL-1 beta
#287CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT
#288ANTI IL-36R ANTIBODIES
#289IL-11Rα antibodies
#290Methods and compositions for diagnosis and treatment of autoimmune disease secondary to multiple sclerosis by assessing genotypes associated with elevated IL-21
#291Determining toxicity risk in CAR T-cell therapy
#292IN VITRO IMMUNE SYNAPSE SYSTEM AND METHOD OF IN VITRO EVALUATING IMMUNE RESPONSE USING THE SAME
#293Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A function
#294IL-10, S100B AND H-FABP MARKERS AND THEIR USE IN DETECTING TRAUMATIC BRAIN INJURY
#295Methods for prediction of anti-TNF α drug levels and autoantibody formation
#296NOVEL INTERLEUKIN-17A-SPECIFIC AND INTERLEUKIN-23-SPECIFIC BINDING POLYPEPTIDES AND USES THEREOF
#297METHODS AND COMPOSITIONS FOR MODULATING INNATE LYMPHOID CELL PATHOGENIC EFFECTORS
#298Compositions and methods for treating age-related diabetes and related disorders
#299PEPTIDES FOR USE IN TREATMENT AND DIAGNOSIS OF TYPE 1 DIABETES
#300Anti-IL-23 antibodies, compositions, methods and uses